Pathophysiology of Acute Myeloid Leukemia.
Wachter F, Pikman Y.
Acta Haematol. 2024;147(2):229-246. doi: 10.1159/000536152. Epub 2024 Feb 16.
How I treat acute myeloid leukemia with differentiation therapy.
Issa GC, Stein EM, DiNardo CD.
Blood. 2025 Mar 20;145(12):1251-1259. doi: 10.1182/blood.2024024008.
Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
Cheng WY, Li JF, Zhu YM, Lin XJ, Wen LJ, Zhang F, Zhang YL, Zhao M, Fang H, Wang SY, Lin XJ, Qiao N, Yin W, Zhang JN, Dai YT, Jiang L, Sun XJ, Xu Y, Zhang TT, Chen SN, Zhu HH, Chen Z, Jin J, Wu DP, Shen Y, Chen SJ.
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2211429119. doi: 10.1073/pnas.2211429119. Epub 2022 Nov 28.
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D, Dick JE.
Nat Med. 1997 Jul;3(7):730-7. doi: 10.1038/nm0797-730.
Advances in acute myeloid leukemia differentiation therapy: A critical review.
Abdel-Aziz AK.
Biochem Pharmacol. 2023 Sep;215:115709. doi: 10.1016/j.bcp.2023.115709. Epub 2023 Jul 26.
miRNAs in acute myeloid leukemia.
Liao Q, Wang B, Li X, Jiang G.
Oncotarget. 2017 Jan 10;8(2):3666-3682. doi: 10.18632/oncotarget.12343.
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations.
Selheim F, Aasebø E, Reikvam H, Bruserud Ø, Hernandez-Valladares M.
Int J Mol Sci. 2024 May 7;25(10):5080. doi: 10.3390/ijms25105080.
Acute myeloid leukemia: therapeutic targeting of stem cells.
Pabon CM, Abbas HA, Konopleva M.
Expert Opin Ther Targets. 2022 Jun;26(6):547-556. doi: 10.1080/14728222.2022.2083957. Epub 2022 Jun 2.
Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia.
Hogeling SM, Lê DM, La Rose N, Kwon MC, Wierenga ATJ, Van den Heuvel FAJ, Van den Boom V, Kuchnio A, Philippar U, Huls G, Schuringa JJ.
Haematologica. 2025 Jun 1;110(6):1278-1291. doi: 10.3324/haematol.2024.285616. Epub 2024 Dec 19.
Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.
Ngo S, Oxley EP, Ghisi M, Garwood MM, McKenzie MD, Mitchell HL, Kanellakis P, Susanto O, Hickey MJ, Perkins AC, Kile BT, Dickins RA.
Nat Commun. 2021 Nov 11;12(1):6546. doi: 10.1038/s41467-021-26849-w.
